home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Establishing a Reduced Testing Program for Pharmaceutical & Medical Device Components - Webinar By GlobalCompliancePanel

 
  September 11, 2011  
     
 


global compliance panel, Online Training Webinar
2011-09-22


Why should you attend: Only you can determine the need to attend this webinar. I would like to offer a suggestion. Why not review the principles explained in this informational packet and then compare your system structure to the elements outlined here. If your system includes all of these elements, that's great. Then, join us to learn a new perspective. However, if you see some potential vulnerability, please join us to learn more and gain insight for improving your reduced material testing program.

This course will help you understand the lifecycle for the reduced testing of pharmaceutical and medical device components. This lifecycle begins by explaining the steps of a successful reduced testing program that include material qualification, general supplier qualification, supplier qualification for reduced testing, establishing criteria for sampling, role of validation, the role of the laboratory, test methods, comparing analytical results, analyzing the Certificate of Analysis (COA), and monitoring to ensure continued compliance with the regulations. This understanding of the lifecycle will help you confidently present arguments to management for establishing, designing, training and implementing, and managing the reduced testing process.

Areas Covered in the Session:
  • A Brief Quality Lesson
  • Defining the Reduced Testing of Components Environment
  • Regulatory Requirements and Current Industry Practices for Reduced Testing.
  • Advantages and Disadvantages of Reduced Testing
  • Players, Roles, And Responsibilities-Interdepartmental roles in establishing and maintaining a reduced testing program.
  • A study of the reduced testing lifecycle in graphical format , including specification control, material qualification, researching and selecting suppliers, supplier auditing (including selection of audit team members) and qualification, corrective actions, handling certificates of analysis, maintaining supplier quality and control, supplier change control, and handling problems suppliers.
  • A Risk Based Sampling Plan To Determine Sample Size and Frequency
  • Planning for Implementing a Reduced Testing Plan
  • Implementing a Reduced Testing Program
  • Action Steps 
  • Maintaining The System
Who Will Benefit:
  • Material Laboratory Managers & Personnel
  • Incoming Warehouse
  • Purchasing & Production
  • Quality Assurance Managers
 
 
Organized by: global compliance panel
Invited Speakers:
Howard enjoys sharing his 30 years plus experience in starting up, developing, implementing, managing, and remediating pharmaceutical and medical device quality systems. He has a BS in Biology/Chemistry and Political Science as well as work toward an MBA. His ability to quickly learn the technology is demonstrated by his success in applying quality assurance principles to a wide range of pharmaceuticals and medical devices. He is a Certified Biomedical Auditor (CBA), Certified Quality Manager (CQM), and Quality Auditor (CQA). His technical education is further complemented by his Political Science degree helping him understand the regulatory process; his work toward an MBA provides business insight. He is a member of ASQ, PDA, AAMI, RAPS, and SQA. He strongly believes that Quality is very influential in shaping successful operations. He knows how to use his leadership abilities to build organizational relationships that make systems operate effectively as well as to develop and empower people.
 
Deadline for Abstracts: 2011-09-22
 
Registration:
Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00

webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com

Phone: 800-447-9407
Fax: 302-288-6884

E-mail: webinars@globalcompliancepanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.